Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inventiva S.A. ADR (NQ: IVA ) 1.871 +0.041 (+2.27%) Streaming Delayed Price Updated: 3:45 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Inventiva S.A. ADR < Previous 1 2 3 4 Next > Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday October 07, 2022 We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! Via InvestorPlace Inventiva's NASH Pact In China Represents 'Financially Prudent Pathway,' Says This Analyst September 26, 2022 Via Benzinga Week In Review: Sino Biopharma Subsidiary Enters $307 Million Agreement For Rights To NASH Candidate September 24, 2022 Chia Tai-Tianqing Pharma, a subsidiary of Sino Biopharma, in-licensed Greater China rights to a therapy for non-alcoholic steatohepatitis from Inventiva in a $307 million deal. Meanwhile, CASI Pharma... Via Talk Markets Dow Turns Higher; Crude Oil Rises 0.7% September 22, 2022 U.S. stocks pared some losses, with the Dow Jones turning higher toward the end of trading on Thursday. Via Benzinga Inventiva Inks Licensing Pact With China-Based Sino Biopharm For NASH Candidate In Greater China September 22, 2022 Via Benzinga Inventiva Raises €50M Debt Financing To Fund Its Lead Program In NASH Patients May 16, 2022 Via Benzinga Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session September 22, 2022 Gainers Via Benzinga Nasdaq Drops Over 100 Points; Spero Therapeutics Shares Spike Higher September 22, 2022 U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Thursday. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 22, 2022 Gainers Spero Therapeutics (NASDAQ:SPRO) shares moved upwards by 122.7% to $1.83 during Thursday's pre-market session. The market value of their outstanding shares is at $64.1 million. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session September 21, 2022 Gainers Pulmatrix (NASDAQ:PULM) shares rose 11.9% to $4.3 during Wednesday's after-market session. The company's market cap stands at $14.5 million. Via Benzinga Earnings Scheduled For September 21, 2022 September 21, 2022 Companies Reporting Before The Bell • General Mills (NYSE:GIS) is projected to report quarterly earnings at $1.00 per share on revenue of $4.72 billion. Via Benzinga Stocks That Hit 52-Week Lows On Thursday July 21, 2022 During Thursday's trading, 50 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday August 02, 2022 Tuesday's session saw 63 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday July 19, 2022 Tuesday saw 37 companies set new 52-week lows. Via Benzinga 51 Biggest Movers From Yesterday April 07, 2022 Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares climbed 79.7% to close at $3.63 on Wednesday. Advent Technologies and Hyundai Motor Company entered into... Via Benzinga 40 Stocks Moving In Wednesday's Mid-Day Session April 06, 2022 Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares jumped 77.7% to $3.5950. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales... Via Benzinga 21 Stocks Moving in Wednesday's Pre-Market Session April 06, 2022 Gainers Dakota Gold (NYSE: DC) shares rose 97.1% to $13.60 in pre-market trading. The company’s stock was uplisted to NYSE American on Tuesday. BigBear.ai Holdings,... Via Benzinga The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout March 08, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... Via Benzinga FDA Gives Green Signal To Inventiva's Mid-Stage Lanifibranor Study In NASH Patients March 08, 2022 The FDA has completed a safety review of Inventiva SA's (NASDAQ: IVA) IND application and signed off Phase 2 combination trial with its lead drug candidate... Via Benzinga Earnings Scheduled For March 7, 2022 March 07, 2022 Companies Reporting Before The Bell • Niu Technologies (NASDAQ:NIU) is expected to report quarterly earnings at $0.21 per share on revenue of $144.02 million. •... Via Benzinga The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program February 01, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Inventiva Posts Results of Clinical Thorough QT Study Of Lanifibranor December 07, 2021 Inventiva (NASDAQ: IVA) announced the results of a clinical thorough QT/QTc study demonstrating the safety of lanifibranor on cardiac electrical activity. The... Via Benzinga Inventiva Plans To Start Lanifibranor Combo Study In NASH, Diabetes In 2022 October 28, 2021 Inventiva (NASDAQ: IVA) announced the design of Phase 2a combination trial of lanifibranor in patients with type 2 diabetes (T2D) and non-cirrhotic non-alcoholic... Via Benzinga Fast Track Status Expanded For Inventiva's NASH Treatment September 22, 2021 The FDA has decided that the Fast Track designation previously granted to Inventiva SA's (NASDAQ: IVA) lanifibranor in NASH encompasses the treatment of NASH... Via Benzinga Exposures Product Safety Earnings Scheduled For September 20, 2021 September 20, 2021 Companies Reporting Before The Bell • Cognyte Software (NASDAQ:CGNT) is expected to report quarterly earnings at $0.15 per share on revenue of $115.57 million. ... Via Benzinga The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs September 22, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session August 05, 2021 Gainers Ensysce Biosciences (NASDAQ:ENSC) shares rose 42.78% to $5.84 during Thursday's pre-market session. The company's market cap stands at $141.7 million.... Via Benzinga The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization September 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma August 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts August 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... Via Benzinga Exposures COVID-19 < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.